Medicine and Dentistry
Hepatocellular Carcinoma
100%
Chronic Kidney Disease
69%
Malignant Neoplasm
61%
Cohort Analysis
48%
Neoplasm
35%
Disease
33%
Liver Cirrhosis
33%
Prevalence
31%
Diabetes
28%
Odds Ratio
28%
Cardiovascular Disease
28%
COVID-19
26%
Blood Pressure
26%
Body Mass Index
26%
Cardiovascular System
24%
Overall Survival
24%
Human Immunodeficiency Virus
24%
Biological Marker
23%
Clinical Trial
22%
Brain Ischemia
21%
Hazard Ratio
20%
Lung Cancer
20%
Pediatrics
19%
Semaglutide
17%
Primary Health Care
17%
Meta-Analysis
17%
Systematic Review
16%
Logistic Regression Analysis
16%
Heart Failure
15%
Colorectal Cancer
15%
Magnetic Resonance Imaging
15%
Drug Therapy
15%
Adverse Event
14%
Symptom
13%
Health Care Cost
13%
Infection
13%
Glomerular Filtration Rate
13%
Maturity Onset Diabetes of the Young
13%
Health System
13%
Systolic Blood Pressure
12%
Health Care
12%
Non Small Cell Lung Cancer
12%
Apoplexy
12%
Placebo
12%
Randomized Controlled Trial
12%
Clinician
12%
Randomized Clinical Trial
12%
Bariatric Surgery
12%
Radiation Therapy
11%
Obesity
11%
Proportional Hazards Model
11%
Immune Checkpoint Inhibitor
11%
Adolescent
10%
Hemoglobin A1c
10%
Ethnic Disparity
10%
Cardiovascular Risk
10%
Colorectal Cancer Screening
10%
Colonoscopy
10%
Liver Cancer
10%
Hepatitis C Virus
10%
Retrospective Cohort Study
10%
Medicare
9%
Quality of Life
9%
Emergency Department
9%
Cross Sectional Study
9%
Diagnosis
9%
Hepatitis C
9%
Kidney Function
9%
Racial Disparity
9%
Symptomatic Treatment
9%
Disease Exacerbation
8%
Veterans Health
8%
Breast Cancer
8%
Antihypertensive Agent
8%
Computer Assisted Tomography
8%
End Stage Renal Disease
8%
Cancer Screening
8%
Nephropathy
7%
Opiate
7%
Recurrent Disease
7%
Nonalcoholic Fatty Liver
7%
Immunotherapy
7%
Liver Transplantation
7%
Oncology
7%
Outpatient
7%
Lung Cancer Screening
7%
Patient Care
7%
Injury
7%
Cohort Effect
7%
Cancer Diagnosis
7%
Public Health
6%
All Cause Mortality
6%
Electronic Health Record
6%
Physical Activity
6%
Surgery
6%
Liver Disease
6%
Atherosclerosis
6%
Cognitive Defect
6%
Telehealth
6%
Attitude
5%
Keyphrases
Hepatocellular Carcinoma
46%
Confidence Interval
43%
Chronic Kidney Disease
37%
Chronic Renal Insufficiency Cohort
33%
United States
28%
Acute Ischemic Stroke
24%
Hepatocellular Carcinoma Surveillance
19%
Cirrhosis
18%
Hazard Ratio
18%
Odds Ratio
17%
Body Mass Index
16%
Ischemic Stroke
16%
Overall Survival
16%
Blood Pressure
16%
Diabetes
15%
Clinical Outcomes
14%
Older Adults
14%
Cardiovascular Disease
14%
Bogalusa Heart Study
14%
Type 2 Diabetes Mellitus (T2DM)
13%
Cardiovascular Risk
13%
Obesity
13%
China
12%
Kidney Disease Progression
12%
All-cause Mortality
12%
Semaglutide
12%
Immune Checkpoint Inhibitors
11%
Major Depressive Disorder
11%
Systolic Blood Pressure
11%
Risk Factors
11%
Placebo
10%
Estimated Glomerular Filtration Rate
10%
Meta-analysis
10%
Heart Failure
10%
Tumor
9%
COVID-19
9%
Racial Disparities
9%
Non-Hispanic White
9%
Non-small Cell Lung Cancer (NSCLC)
9%
Multivariable
9%
Randomized Clinical Trial
8%
Hypertension
8%
Hemoglobin A1c (HbA1c)
8%
Major Disability
8%
Ischemic Stroke Patients
8%
Randomized Controlled Trial
8%
Cardiovascular Outcomes
8%
Texas
8%
Hispanic
8%
Acute Ischemic Stroke Patients
8%
Clinical Trials
8%
Type 2 Diabetic Patients
7%
Hospitalization
7%
Clinical Practice
7%
Cardiovascular Mortality
7%
Overweight or Obesity
7%
Depressive Symptoms
7%
Retrospective Cohort Study
6%
High Risk
6%
Colorectal Cancer
6%
Race-ethnicity
6%
Adjusted Odds Ratio
6%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
6%
Weight Loss
6%
Vascular Events
6%
Lung Cancer
6%
Systematic Meta-analysis
6%
Antidepressants
6%
Improved Outcomes
6%
CRIC Study
6%
Phase II Trial
6%
Colorectal Cancer Screening
6%
Hypertension Management
5%
Bariatric Surgery
5%
Prognostic Value
5%
Cardiac Biomarkers
5%
Without Diabetes
5%
Once-weekly Semaglutide
5%
End-stage Renal Disease
5%
Ultrasound
5%
Inflammation
5%
Glucagon-like
5%
Adverse Events
5%
Patients with Diabetes
5%
Stereotactic Ablative Radiotherapy
5%
Youth Depression
5%
AIDS/HIV
5%
Metabolic Surgery
5%
Receptor Agonist
5%
Psychometric Properties
5%
Patient Health Questionnaire-9 (PHQ-9)
5%
A1 Receptor
5%
Death Events
5%
Cardiovascular Events
5%
Immune-related Adverse Events
5%
Atherosclerotic Cardiovascular Disease (ASCVD)
5%
Curative Treatment
5%
Growth Differentiation factor-15 (GDF-15)
5%
Cystic Fibrosis
5%
Acute Phase
5%